MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 12.35
-0.05 (-0.40%)
Apr 20, 2026, 1:22 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 805.78 million as of April 20, 2026. Its market cap has decreased by -5.68% in one year.
Market Cap
805.78M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
12.35
Market Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 805.78M, a decrease of -61.87%. That is a compound annual growth rate of -19.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 802.54M | -0.40% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lukas Biomedical | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| GeneReach Biotechnology | 1.12B |
| Level Biotechnology | 1.09B |
| TCI GENE | 967.06M |
| NatureWise Biotech & Medicals | 897.75M |
| BioLASCO Taiwan | 778.60M |
| Neith | 749.77M |